acetylcysteine has been researched along with Vascular Diseases in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (38.46) | 29.6817 |
| 2010's | 5 (38.46) | 24.3611 |
| 2020's | 3 (23.08) | 2.80 |
| Authors | Studies |
|---|---|
| Bastida, A; Chioua, M; Colmena, I; de los Ríos, C; Del Barrio, L; Gandía, L; González-Lafuente, L; López, MG; Marco-Contelles, J; Martín-de-Saavedra, MD; Romero, A; Samadi, A; Valderas, C; Villarroya, M | 1 |
| Ge, X; He, C; Huang, C; Liu, S; Yang, C; Yang, S; Zhang, X | 1 |
| C S, G; Rupakumar, T; T, PK; Tandra, HV; V R, P; Vijayasekharan, K | 1 |
| Burgos, ES; Charron, MJ; Manuel, CR; Munnangi, S; Pekson, R; Reznik, SE; Vuguin, PM; Williams, L | 1 |
| Gilbert, A; Hodovan, J; Kumar, K; Lindner, JR; Moulton, B; Olson, S; Wood, MD; Wu, MD | 1 |
| Oishi, R; Yamada, T; Yano, T | 1 |
| Jo, I; Kim, YO; Lee, HS; Park, JS; Seo, J | 1 |
| Desai, KM; Dhar, A; Dhar, I; Wu, L | 1 |
| Allaqaband, S; Bajwa, T; Hafiz, AM; Jan, MF; Mori, N; Shaikh, F; Wallach, J | 1 |
| Ardia, A; Goodman, SR; Mulekar, M; Pace, BS; Pack-Mabien, A; Shartava, A | 1 |
| Davies, JE; Jennings, SC; Ng, LL; Pettit, AI; Quinn, PA; Wong, RK | 1 |
| Khashab, M; Kwo, PY; Tector, AJ | 1 |
| Marsden, PA | 1 |
2 review(s) available for acetylcysteine and Vascular Diseases
| Article | Year |
|---|---|
Pharmacological elucidation and pharmaceutical intervention to reduce antitumor drug-induced vascular injury.
Topics: Acetylcysteine; Antineoplastic Agents; Cells, Cultured; Endothelium, Vascular; Glutathione; Humans; Vascular Diseases; Vinblastine; Vinorelbine | 2013 |
Epidemiology of acute liver failure.
Topics: Acetaminophen; Acetylcysteine; Analgesics, Non-Narcotic; Drug-Related Side Effects and Adverse Reactions; Free Radical Scavengers; Hepatitis, Autoimmune; Hepatitis, Viral, Human; Humans; Liver Failure, Acute; Liver Transplantation; Metabolic Diseases; Neoplasms; Prognosis; Vascular Diseases | 2007 |
2 trial(s) available for acetylcysteine and Vascular Diseases
| Article | Year |
|---|---|
Prevention of contrast-induced acute kidney injury in patients with stable chronic renal disease undergoing elective percutaneous coronary and peripheral interventions: randomized comparison of two preventive strategies.
Topics: Acetylcysteine; Administration, Oral; Aged; Aged, 80 and over; Biomarkers; Cardiac Catheterization; Catheterization, Peripheral; Chi-Square Distribution; Contrast Media; Coronary Angiography; Creatinine; Female; Fluid Therapy; Humans; Infusions, Intravenous; Kidney Diseases; Logistic Models; Male; Middle Aged; Multivariate Analysis; Prospective Studies; Renal Insufficiency; Risk Assessment; Risk Factors; Sodium Bicarbonate; Sodium Chloride; Time Factors; Treatment Outcome; Vascular Diseases; Wisconsin | 2012 |
Effects of N-acetylcysteine on dense cell formation in sickle cell disease.
Topics: Acetylcysteine; Adolescent; Adult; Anemia, Sickle Cell; Double-Blind Method; Erythrocytes, Abnormal; Female; Glutathione; Humans; Male; Placebos; Vascular Diseases | 2003 |
9 other study(ies) available for acetylcysteine and Vascular Diseases
| Article | Year |
|---|---|
Cholinergic and neuroprotective drugs for the treatment of Alzheimer and neuronal vascular diseases. II. Synthesis, biological assessment, and molecular modelling of new tacrine analogues from highly substituted 2-aminopyridine-3-carbonitriles.
Topics: Acetylcholinesterase; Alzheimer Disease; Cell Line, Tumor; Cholinesterase Inhibitors; Humans; Kinetics; Models, Molecular; Neuroprotective Agents; Nitriles; Tacrine; Vascular Diseases | 2011 |
N-Acetylcysteine protects against cobalt chloride-induced endothelial dysfunction by enhancing glucose-6-phosphate dehydrogenase activity.
Topics: Acetylcysteine; Cobalt; Glucosephosphate Dehydrogenase; Human Umbilical Vein Endothelial Cells; Humans; Hypoxia; Vascular Diseases | 2022 |
A stitch in time saves nine: timely use of N-acetyl cysteine (NAC) for chemotherapy-induced veno-occlusive disease (VOD)-is it a cost-effective alternative?
Topics: Acetylcysteine; Antineoplastic Agents; Child; Cost-Benefit Analysis; Hematopoietic Stem Cell Transplantation; Hepatic Veno-Occlusive Disease; Humans; Polydeoxyribonucleotides; Vascular Diseases | 2022 |
N-Acetylcysteine Resolves Placental Inflammatory-Vasculopathic Changes in Mice Consuming a High-Fat Diet.
Topics: Acetylcysteine; Animals; Diet, High-Fat; Disease Models, Animal; Female; Inflammation; Male; Maternal Nutritional Physiological Phenomena; Mice; Mice, Transgenic; Placenta; Pregnancy; Pregnancy Complications; Vascular Diseases | 2019 |
Ponatinib coronary microangiopathy: novel bedside diagnostic approach and management with N-acetylcysteine.
Topics: Acetylcysteine; Humans; Imidazoles; Pyridazines; Vascular Diseases | 2020 |
Coordinated regulation of angiopoietin-1 and vascular endothelial growth factor by arsenite in human brain microvascular pericytes: implications of arsenite-induced vascular dysfunction.
Topics: Acetylcysteine; Actins; Angiopoietin-1; Arsenites; Blotting, Western; Brain Chemistry; Capillaries; Cells, Cultured; Cloning, Molecular; Dose-Response Relationship, Drug; Humans; Immunohistochemistry; Pericytes; Reverse Transcriptase Polymerase Chain Reaction; Teratogens; Vascular Diseases; Vascular Endothelial Growth Factor A | 2009 |
Methylglyoxal scavengers attenuate endothelial dysfunction induced by methylglyoxal and high concentrations of glucose.
Topics: Acetylcholine; Acetylcysteine; Animals; Aorta; Cells, Cultured; Cyclic GMP; Endothelial Cells; Glucose; Guanidines; Humans; Male; Nitric Oxide; Nitric Oxide Synthase; Phosphorylation; Pyruvaldehyde; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Vascular Diseases; Vasodilation | 2010 |
Advanced glycation end products stimulate an enhanced neutrophil respiratory burst mediated through the activation of cytosolic phospholipase A2 and generation of arachidonic Acid.
Topics: Acetylcysteine; Adult; Arachidonic Acid; Arachidonic Acids; Cells, Cultured; Enzyme Inhibitors; Glycation End Products, Advanced; Group IV Phospholipases A2; Humans; Indomethacin; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Organophosphonates; Oxidation-Reduction; Phospholipases A; Phospholipases A2; Quinacrine; Reactive Oxygen Species; Respiratory Burst; Vascular Diseases | 2003 |
Low-molecular-weight S-nitrosothiols and blood vessel injury.
Topics: Acetylcysteine; Animals; Basic Helix-Loop-Helix Transcription Factors; Blood Vessels; Humans; Hypertension, Pulmonary; Molecular Weight; Nitric Oxide; S-Nitrosothiols; Vascular Diseases | 2007 |